Obviously the answer is to fund executive salary the next 30 years if we could only get them to admit it.
100 patient trials run roughly 10 million for a 15 week length. Much less if they have more patients or run for a longer length of time which I would prefer. Not so sure their cash would have made it another 18 to 24 months. In fact i'm sure it wouldn't have. Probably best they already raised the cash considering what else has transpired.
Market Data 
Markets 
AI
